Harry Finch,Craig Fox,Mohammed Sajad,Monique Bondil Van Niel,Andrew Forrest
申请号：
US14246695
公开号：
US09078885B2
申请日:
2014.04.07
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A pharmaceutical composition adapted for pulmonary administration by inhalation is described, wherein the composition comprises a glitazone and one or more pharmaceutically acceptable carriers and/or excipients, wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer, and wherein the glitazone is pioglitazone or rosiglitazone or a pharmaceutically acceptable salt thereof, and wherein the glitazone is in the form of microparticles.
